Contribution of pressure and flow changes to resistance reduction after pulmonary arterial hypertension treatment: a meta-analysis of 3898 patients
IT Farmakis, A Baroutidou, V Patsiou… - ERJ Open …, 2024 - Eur Respiratory Soc
Background Pulmonary arterial hypertension (PAH)-targeted therapies exert significant
haemodynamic changes; however, systematic synthesis is currently lacking. Methods We …
haemodynamic changes; however, systematic synthesis is currently lacking. Methods We …
[HTML][HTML] Contribution of pressure and flow changes to resistance reduction after pulmonary arterial hypertension treatment: a meta-analysis of 3898 patients
IT Farmakis, A Baroutidou, V Patsiou… - ERJ Open …, 2024 - ncbi.nlm.nih.gov
Background Pulmonary arterial hypertension (PAH)-targeted therapies exert significant
haemodynamic changes; however, systematic synthesis is currently lacking. Methods We …
haemodynamic changes; however, systematic synthesis is currently lacking. Methods We …
Contribution of pressure and flow changes to resistance reduction after pulmonary arterial hypertension treatment: a meta-analysis of 3898 patients
IT Farmakis, A Baroutidou, V Patsiou… - ERJ open …, 2024 - pubmed.ncbi.nlm.nih.gov
Background Pulmonary arterial hypertension (PAH)-targeted therapies exert significant
haemodynamic changes; however, systematic synthesis is currently lacking. Methods We …
haemodynamic changes; however, systematic synthesis is currently lacking. Methods We …
Contribution of pressure and flow changes to resistance reduction after pulmonary arterial hypertension treatment: a meta-analysis of 3898 patients
I Farmakis, A Baroutidou, V Patsiou… - ERJ Open …, 2024 - europepmc.org
Background Pulmonary arterial hypertension (PAH)-targeted therapies exert significant
haemodynamic changes; however, systematic synthesis is currently lacking. Methods We …
haemodynamic changes; however, systematic synthesis is currently lacking. Methods We …
Contribution of pressure and flow changes to resistance reduction after pulmonary arterial hypertension treatment. a meta-analysis of 3898 patients
IT Farmakis, A Baroutidou, V Patsiou… - ERJ OPEN …, 2024 - iris.uniroma1.it
Background: Pulmonary arterial hypertension (PAH)-targeted therapies exert significant
haemodynamic changes; however, systematic synthesis is currently lacking. Methods: We …
haemodynamic changes; however, systematic synthesis is currently lacking. Methods: We …
Contribution of pressure and flow changes to resistance reduction after pulmonary arterial hypertension treatment: a meta-analysis of 3898 patients
IT Farmakis, A Baroutidou, V Patsiou… - ERJ Open …, 2023 - Eur Respiratory Soc
Background Pulmonary arterial hypertension (PAH)-targeted therapies exert significant
hemodynamic changes, however systematic synthesis is currently lacking. Methods We …
hemodynamic changes, however systematic synthesis is currently lacking. Methods We …
Contribution of pressure and flow changes to resistance reduction after pulmonary arterial hypertension treatment: a meta-analysis of 3898 patients.
IT Farmakis, A Baroutidou, V Patsiou… - ERJ Open …, 2024 - europepmc.org
Background Pulmonary arterial hypertension (PAH)-targeted therapies exert significant
haemodynamic changes; however, systematic synthesis is currently lacking. Methods We …
haemodynamic changes; however, systematic synthesis is currently lacking. Methods We …
[PDF][PDF] Contribution of pressure and flow changes to resistance reduction after pulmonary arterial hypertension treatment: a meta-analysis of 3898 patients
IT Farmakis, A Baroutidou, V Patsiou, A Arvanitaki… - 2024 - iris.uniroma1.it
Background Pulmonary arterial hypertension (PAH)-targeted therapies exert significant
haemodynamic changes; however, systematic synthesis is currently lacking. Methods We …
haemodynamic changes; however, systematic synthesis is currently lacking. Methods We …